Systemic Sclerosis Is Not Associated With Worse Outcomes of Patients Admitted for Ischemic Stroke: Analysis of the National Inpatient Sample.
cardiovascular
cerebrovascular accident
ischemic stroke
outcome
rheumatology
scleroderma
systemic sclerosis
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
12 Jul 2020
12 Jul 2020
Historique:
entrez:
14
8
2020
pubmed:
14
8
2020
medline:
14
8
2020
Statut:
epublish
Résumé
Introduction Systemic sclerosis (SSc) is known to increase the risk of ischemic stroke and other cerebrovascular events. It is, however, unclear if SSc negatively impacts the outcomes of ischemic stroke hospitalizations. This study aims to compare the outcomes of patients primarily admitted for ischemic stroke with and without a secondary diagnosis of SSc. Methods Data were extracted from the National Inpatient Sample (NIS) 2016 and 2017 database. NIS is the largest hospitalization database in the United States. We searched the database for hospitalizations of adult patients admitted with a principal diagnosis of ischemic stroke, with and without SSc as the secondary diagnosis using International Classification of Diseases, Tenth Revision (ICD-10) codes. The primary outcome was inpatient mortality, and secondary outcomes were hospital length of stay (LOS), total hospital charge, odds of undergoing mechanical thrombectomy, and receiving tissue plasminogen activator (TPA). Multivariate logistic and linear regression analysis was used to adjust for confounders. Results Over 71 million discharges were included in the NIS database for the years 2016 and 2017. Out of 525,570 hospitalizations for ischemic stroke, 410 (0.08%) had SSc. Hospitalizations for ischemic stroke with SSc had similar inpatient mortality (6.10% vs 5.53%, adjusted OR 0.66, 95% CI (0.20-2.17); p=0.492), length of stay (LOS) (5.9 vs 5.7 days; p=0.583), and total hospital charge ($74,958 vs $70,197; p=0.700) compared to those without SSc. Odds of receiving TPA (9.76% vs 9.29%, AOR 1.08, 95% CI (0.51-2.27), P=0.848) and undergoing mechanical thrombectomy (7.32% vs 5.06%, AOR 0.75, 95% CI (0.28-1.98), P=0.556) was similar between both groups. Conclusions Hospitalizations for ischemic stroke with SSc had similar inpatient mortality, LOS, total hospital charge, odds of receiving TPA, and mechanical thrombectomy compared to those without SSc.
Identifiants
pubmed: 32789091
doi: 10.7759/cureus.9155
pmc: PMC7417321
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e9155Informations de copyright
Copyright © 2020, Edigin et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ann Transl Med. 2015 Jan;3(1):8
pubmed: 25705640
Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):3-23
pubmed: 30277868
Mediterr J Rheumatol. 2019 Mar 28;30(1):7-15
pubmed: 32185337
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064
Cleve Clin J Med. 2019 Oct;86(10):685-695
pubmed: 31597076
Arthritis Res Ther. 2011 Aug 26;13(4):237
pubmed: 21888685
Stroke. 2016 Apr;47(4):943-50
pubmed: 26917565
Ther Adv Musculoskelet Dis. 2010 Jun;2(3):145-53
pubmed: 22870444
Acta Reumatol Port. 2016 Jan-Mar;41(1):6-7
pubmed: 27115102
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):3-20
pubmed: 29035173
Indian J Crit Care Med. 2019 Jun;23(Suppl 2):S140-S146
pubmed: 31485123
Rheumatology (Oxford). 2013 Jan;52(1):161-5
pubmed: 23238980
J Am Heart Assoc. 2019 Sep 3;8(17):e013405
pubmed: 31446827
J Rheumatol. 2020 Jan;47(1):82-88
pubmed: 30877213
Mod Rheumatol. 2016;26(1):128-31
pubmed: 26025436